PET during, after chemotherapy predicted outcomes in follicular lymphoma

November 27, 2012

PET at an interim point and after treatment predicted survival outcomes in a cohort of patients with previously untreated follicular lymphoma, according to results of a prospective study.

The study included 121 patients with high tumor burden. The prognostic value of [18F] fluorodeoxyglucose (FDG) PET has not been examined in patients with this disease who were treated with first-line immunochemotherapy, according to the researchers.